It looks like I stand corrected. I originally Googled Haber and Bavi. I got a what looked like a correlation, but as I am digging further, it does look like my post was incorrect. Moderators, please delete.
You are correct, but Dr. Haber he is also a professor of oncology at Harvard Medical School. And PPHM's pancreatic trial's principal investigator is from Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School in Boston per the PR below. I'd bet Dr. Haber is very well-informed about bavituximab.